Microbiological and Organizational Impact of the Use of Bacteriologically Controlled Water in COLOscopy
Condition(s) studied
Investigational drug(s) / intervention(s)
Colonoscopy with Bacteriological Controlled Water: Patient with coloscopy which used Bacteriological Controlled Water : Collection of 250 ml of bacteriologically controlled water from the wash bottle at the end of each water-assisted colonoscopy to test for enterobacteria and fecal streptococci
Study summary
A joint opinion of the SFED and the SF2H recommends to orient our colonoscopy practices towards the use of bacteriologically controlled water in reusable bottles for colonic irrigation. To date, no study exists to validate the proposed set-up. Our main objective is therefore to evaluate the microbiological safety of the use of bacteriologically controlled water, in particular the absence of retro contamination of the water in the wash bottle by the faecal flora of the patient undergoing colonoscopy, in order to be able to generalise this practice
Eligibility
Primary outcome measure(s)
- Rate of back contamination — inclusion visit
Rate of back contamination after colonoscopy using the EBM procedure. The absence of retro-contamination is defined as the absence of fecal flora (enterobacteria and fecal streptococci) in the wash bottle during the bacteriological analysis of the EBM microbiological samples taken after each colonoscopy
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHU de Bordeaux - Hôpital haut Lévêque | Pessac | France | Recruiting |
More University Hospital, Bordeaux trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06688955 on ClinicalTrials.gov ↗ ← All trials in France